Love Science
International Meetings
Networks & Collaborations
NEWS
ABOUT
About Us
The mission of ISCaM (ex ISPDC, International Society for Proton Dynamics in Cancer) is to improve communication and to foster collaborative activities and research programs between European and non European scientists engaged in acidity, proton dynamics, metabolism and microenvironment in cancer research. ISCaM can consolidate, co-ordinate and facilitate International collaboration, facilitate translation of research to clinical development, and fundraise for Networking activities, scientific programs and projects, scientists mobility, young scientists grants and carrier programs.
AIM
Our Mission
Our mission is to advocate and effectively promote our approach to cancer therapy in the scientific community, social community, Funding Agencies, Governments, and stimulate translation into clinical applications.
To create a critical mass of scientists engaged in research activities on Metabolism in Cancer.
To gain visibility at National, European and International level.
To duly raise the necessary awareness of both the scientific community and society.
To attract resources to finance and conduct research in the field of metabolism in cancer.
To be recognized as an important counterpart for the European Commission, funding agencies and Industry.
To represent the main scientific stakeholder in the field.
THE TEAM
Board Members
Paolo Porporato
President
Professor of Physiology at the Department of Cell and Developmental Biology, University College London; Associate Professor at the Department of Biomedical Sciences, University of Padua and Satellite Group Leader at Francis Crick Institute of London.
His research focuses on understanding how mitochondria provide adaptation during the development of heterogeneous and chemoresistant tumours by studying the transcriptional program underlying mitochondrial biogenesis and the associated metabolic phenotype of cancer subtypes. His research groups use advanced imaging approaches at the UCL campus and perform metabolomic profiling of in vivo tumour models at the Crick institute. He co-founded the Consortium for Mitochondrial Research at UCL
Gyorgy Szabadkai
Past-President
Professor of Physiology at the Department of Cell and Developmental Biology, University College London; Associate Professor at the Department of Biomedical Sciences, University of Padua and Satellite Group Leader at Francis Crick Institute of London.
His research focuses on understanding how mitochondria provide adaptation during the development of heterogeneous and chemoresistant tumours by studying the transcriptional program underlying mitochondrial biogenesis and the associated metabolic phenotype of cancer subtypes. His research groups use advanced imaging approaches at the UCL campus and perform metabolomic profiling of in vivo tumour models at the Crick institute. He co-founded the Consortium for Mitochondrial Research at UCL
Pawel Swietach
President-elect
Professor of Physiology at Oxford University. My laboratory at the Department of Physiology, Anatomy and Genetics (http://www.dpag.ox.ac.uk/) investigates signalling by small molecules in the heart and in cancer, with a particular focus on hydrogen ions, which determine pH. Our ambition is to understand how cells handle their acidic products and how, in turn, acid/base chemistry affects biology.
In 2008, I was awarded a Royal Society University Research Fellowship to study pH regulation in 3-D tissue-like structures, with particular emphasis on cancer physiology. This work is done in collaboration with Professor Adrian L Harris in Oxford.
In 2017, I began two research programmes: one on the role of acid handling and sensing in cancer, with a focus on colorectal cancer, and the other on how acid-base balance is altered in failing hearts.
Fatima Baltazar
Secretary
Associate Professor of Pharmacology at the School of Medicine, University of Minho, Principal Investigator at ICVS (Life and Health Sciences Research Institute) and Coordinator of the Surgical Sciences Research Domain. Fatima’s current research interest is on cancer glycolytic metabolism, especially on monocarboxylate transporters, focusing on the discovery of new cancer prognostic biomarkers and exploitation of therapeutic targets.
Alessandro Carrer
Board Member
Group Leader at the Veneto Institute of Molecular Medicine (VIMM) in Padua. Alessandro investigates metabolic dependencies and their impact on epigenomic reprogramming during pancreatic carcinogenesis.
He trained at University of Pennsylvania and his lab employs mouse transgenics to dissect metabolic and epigenomic perturbations that lead to tumor onset.
Cyril Corbet
Board Member
Research associate from the F.R.S.-FNRS in the Pole of Pharmacology and Therapeutics at UCLouvain in Brussels. Cyril’s research focus is the understanding of the metabolic preferences in relapse-supporting cancer cells and the interplay with the tumor microenvironment along tumor evolution, through the use of patient-derived tumor xenograts and organoid models.
Margherita Cortini
Treasurer
Tenure-track scientist at the Department for Research, Innovation and Technology of the Rizzoli Orthopaedic Specialty Hospital (Istituto Ortopedico Rizzoli) in Bologna, Italy. Margherita’s research focus is the understanding of the interaction between tumor and stromal cells and their reciprocal metabolic reprogramming during primary and metastatic tumor growth.
Social
Twitter Feed
PRESS
Our Publications
and enjoy our benefits
PRICES
Price Table
Reduced
Student - PhD - Post Doc*
€30 /year
€70 /three years
- Reduced fee for ISCaM meetings
- Publish your press & news on ISCaM website
- Elegibility for ISCaM grants & awards
* not more than 5 years after PhD, as proved by a certification letter signed by the tutor.
Regular
.
€100 /year
€250 /three years
- Reduced fee for ISCaM meetings
- Publish your press & news on ISCaM website
Payment with bank transfer
Complete the registration form and send it by e-mail to info@iscam.net together with the document relative to the bank transfer*.
For reduced fee you should also enclose a certification letter signed by the tutor.
Pay on the bank account:
BANCA POPOLARE DELL’EMILIA ROMAGNA
Address: AGENZIA N.6 BOLOGNA, via G. Massarenti 228
Bank account holder: ISCAM INTERNATIONAL SOCIETY OF CANCER MET
IBAN: IT13E0538702598000002394000
SWIFT: BPMOIT22XXX
Object/justification: ISCaM2022 membership “name” + “last name”**.
As a confirmation of your payment you will receive a regular receipt from ISCaM secretariat.
* pay attention! This step is very important.
** pay attention! Specify your last name or we cannot associate the payment to you.
Payment with credit card (MasterCard, Visa, American Express
Send an e-mail to info@iscam.net with the Object/justification: ISCaM2016 membership “name” + “last name”. You can enclose the form or simply write in the text your country of origin, your Insitution, and the type of registration (Regular or Reduced). For reduced fee you should also enclose a certification letter signed by the tutor. As a reply, you will receive an email with a pro-forma invoice with the link for the payment with credit card.
Click on the link and follow the instruction*.
As a confirmation of your payment you will receive a regular receipt from ISCaM secretariat within 10 working days.
* pay attention! If you do not want to register to Paypal, you can choose “Pay with a debit or credit card” and NOT “Pay with my PayPal account”.